Exploring the impact of the recombinant Escherichia coli strain on defensins antimicrobial activity: BL21 versus Origami strain

Abstract The growing emergence of microorganisms resistant to antibiotics has prompted the development of alternative antimicrobial therapies. Among them, the antimicrobial peptides produced by innate immunity, which are also known as host defense peptides (HDPs), hold great potential. They have bee...

Full description

Bibliographic Details
Published in:Microbial Cell Factories
Main Authors: Adrià López-Cano, Marc Martínez-Miguel, Judith Guasch, Imma Ratera, Anna Arís, Elena Garcia-Fruitós
Format: Article
Language:English
Published: BMC 2022-05-01
Subjects:
Host defense peptides
Escherichia coli
Strain
Recombinant protein
Online Access:https://doi.org/10.1186/s12934-022-01803-7

Internet

https://doi.org/10.1186/s12934-022-01803-7

Similar Items